Effectiveness of raloxifene on bone mineral density and serum lipid levels in post-menopausal women with low BMD after discontinuation of hormone replacement therapy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Song, Eun Kyoung. | - |
dc.contributor.author | Yeom, Ji-Hee | - |
dc.contributor.author | Shin, Hyun Taek | - |
dc.contributor.author | Kim, Sanghee | - |
dc.contributor.author | Shin, Wan Gyoon | - |
dc.contributor.author | Oh, Jung-Mi | - |
dc.date.accessioned | 2022-12-21T10:07:05Z | - |
dc.date.available | 2022-12-21T10:07:05Z | - |
dc.date.created | 2022-09-16 | - |
dc.date.issued | 2006-10 | - |
dc.identifier.issn | 0269-4727 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/180890 | - |
dc.description.abstract | Objective: To evaluate the effect of raloxifene on bone mineral density (BMD) and serum lipid levels in post-menopausal women who had discontinued hormone replacement therapy (HRT). Methods: Thirty-four post-menopausal women with low BMD who had taken 60 mg of raloxifene daily for 12 months after discontinuing HRT were evaluated retrospectively. Information about their demographics, fracture history, BMD, lipid profiles and adverse events were collected from medical records and intranet database. The outcome measures were changes in the spine (L2-L4) and femur BMD, serum lipid concentrations, fracture rate and tolerability. Results: The post-menopausal women had a significant increase in their spine (L2-L4) and femur BMD from their baseline BMD [spine, 2.9 +/- 4.6% (P < 0.001); femur, 3.0 +/- 6.6% (P = 0.01)]. Serum low-density lipoprotein (LDL) cholesterol was significantly reduced by 22.6% below baseline after 12 months (P = 0.007). No fractures were observed during therapy. Raloxifene was well tolerated. The most common adverse event was hot flash, which was generally mild. Conclusions: Raloxifene increases BMD at important skeletal sites, and lowers LDL cholesterol with tolerable adverse events. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | WILEY | - |
dc.title | Effectiveness of raloxifene on bone mineral density and serum lipid levels in post-menopausal women with low BMD after discontinuation of hormone replacement therapy | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Yeom, Ji-Hee | - |
dc.identifier.doi | 10.1111/j.1365-2710.2006.00753.x | - |
dc.identifier.scopusid | 2-s2.0-33748364338 | - |
dc.identifier.wosid | 000240202800002 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, v.31, no.5, pp.421 - 427 | - |
dc.relation.isPartOf | JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS | - |
dc.citation.title | JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS | - |
dc.citation.volume | 31 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 421 | - |
dc.citation.endPage | 427 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | ESTROGEN REPLACEMENT | - |
dc.subject.keywordPlus | ALENDRONATE | - |
dc.subject.keywordPlus | PREVENTION | - |
dc.subject.keywordPlus | WITHDRAWAL | - |
dc.subject.keywordPlus | FRACTURES | - |
dc.subject.keywordPlus | HEART | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordAuthor | bone mineral density | - |
dc.subject.keywordAuthor | fracture | - |
dc.subject.keywordAuthor | lipid | - |
dc.subject.keywordAuthor | raloxifene | - |
dc.identifier.url | https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2710.2006.00753.x | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.